Roberto Palenzuela: The Healthcare Executive Building a New Primary-Care Platform

Roberto L. Palenzuela is an American healthcare executive, entrepreneur, and attorney best known as the founder and CEO of Pediatrica Health Group, a rapidly expanding pediatric primary care organization. He is not a celebrity in the conventional entertainment sense; his public relevance comes from more than three decades inside healthcare operations, regulation, acquisitions, and value-based care. That relevance increased considerably in July 2026, when Pediatrica announced a $28 million Series B financing and said its network had reached 21 locations across Florida and Texas. Behind the corporate biography lies a career that began in law and gradually shifted toward the operational side of healthcare delivery.

A Lawyer Who Moved Deep Into Healthcare

Palenzuela’s professional foundation was legal, not clinical.

SEC filings from Metropolitan Health Networks state that he earned a B.B.A. from the University of Miami and a law degree from the University of Miami School of Law in 1988. The Florida Bar independently confirms the law school credentials and records his admission to practice in Florida on October 7, 1988. Its current directory lists him as eligible to practice and a member in good standing, with no discipline reported in the displayed 10-year history.

One small discrepancy is worth preserving rather than smoothing over. Metropolitan’s SEC filing identifies 1985 as the year of his B.B.A., while University of Miami alum materials have listed him as B.B.A. ’84. The undergraduate degree itself is supported; the precise graduation year should therefore not be treated as completely settled without an academic transcript or direct university confirmation.

By the 1990s, Palenzuela was already working at the intersection of law and managed healthcare. Regulatory filings say he served as an officer and director of Community Health Plan of the Rockies, a privately owned Denver-based health maintenance organization, from the mid-1990s into the early 2000s. He also served as general counsel for Universal Rehabilitation Centers of America, later known as Universal Medical Concepts, from 1999 to 2001.

That history matters because the healthcare businesses he later built required more than conventional management experience. Physician networks operate inside a dense system of contracting, reimbursement, compliance, acquisitions and payer relationships. Palenzuela’s career developed inside precisely those areas.

Continucare and Metropolitan Health Networks

In May 2002, Palenzuela became general counsel of Continucare Corporation and later served as its corporate secretary. In March 2004, he moved to Metropolitan Health Networks, where SEC filings identify him as general counsel and secretary. Later public descriptions also associate him with compliance responsibilities.

These were significant years in the consolidation of Florida’s managed-care sector.

Metropolitan announced an agreement in 2011 to acquire Continucare in a cash-and-stock transaction valued at approximately $416 million. Then, in November 2012, Humana agreed to acquire Metropolitan for roughly $850 million plus transaction costs. The acquisition closed on December 21, 2012; Humana later reported a transaction value of approximately $851 million.

Palenzuela was Metropolitan’s general counsel and secretary during that period, placing him within the executive structure surrounding major corporate transactions. That should not be inflated into a claim that he personally engineered either deal: the public transaction records establish his corporate position, but they do not provide a reliable basis for assigning an individual percentage of credit for transactions involving entire management, legal and advisory teams.

This distinction matters in a biography because company profiles sometimes compress complex institutional achievements into a single executive’s accomplishments.

The Shift From Counsel to Operator

By 2014, Palenzuela had moved clearly beyond the traditional general-counsel track.

When the National Parkinson Foundation announced him as a new director that year, it identified him as chief operating officer of Community Medical Group. It described a career of providing regulatory and legal guidance to public and private healthcare companies. The same announcement noted that he had served on CareCloud’s founding board.

That evolution—from attorney advising healthcare organizations to an executive running their operations—is one of the clearest threads in his professional history.

The skills overlap more than they might initially appear. Value-based medical groups depend on payer agreements, compliance systems, acquisitions, physician relationships, reporting infrastructure and disciplined management of reimbursement risk. Palenzuela’s earlier roles exposed him to those mechanics before he began building platforms of his own.

Building ClareMedica

His entrepreneurial profile became much more visible through ClareMedica Health Partners, which he founded and led as CEO.

ClareMedica focused principally on value-based primary care for Medicare Advantage patients in Florida. In July 2019, the company announced a majority equity investment from healthcare-focused private equity firm Beecken Petty O’Keefe & Company. Palenzuela remained CEO as the organization pursued the acquisition and expansion of primary-care practices.

Another major capital event followed in February 2022, when Revelstoke Capital Partners made a significant growth investment. Revelstoke said Palenzuela and the existing management team would continue to lead ClareMedica and retain significant ownership. At the same time, the investment was intended to accelerate the expansion of the company’s value-based care model. Financial terms were not publicly disclosed.

Pediatrica’s current executive biography says Palenzuela ultimately grew ClareMedica into a network of 32 physician practices serving more than 16,000 patients. Those figures come from his current company biography rather than audited public financial statements, so they are best understood as company-reported operating statistics.

The broader trajectory, however, is readily visible: Palenzuela led a physician-focused healthcare platform through institutional investment, acquisition-driven expansion, and a second major private-equity partnership.

Pediatrica Health Group and the Move Into Children’s Care

His next project applied a similar operating philosophy to a different patient population.

In February 2025, Pediatrica Health Group publicly launched through a partnership between Palenzuela and Boston investment firm M33 Growth. The stated aim was to build a pediatric primary-care organization that would give physicians better technology, infrastructure, and administrative support while expanding access for families.

Palenzuela framed the problem primarily as one of resources:

“Putting patient care first has taught me that this also means putting providers first.”
— Roberto L. Palenzuela

Pediatrica then began acquiring established practices rather than building clinics from scratch. During 2025, it announced transactions involving practices in Palm Coast, Coconut Creek, Gainesville, Delray Beach, Manatee County and other Florida communities. The healthcare M&A publication LevinPro later reported that it added 9 practices and 25 physicians in 2025.

Expansion continued in 2026, including acquisitions in Miami Lakes and Miami’s Westchester area.

Then came Pediatrica’s largest publicly announced financing milestone to date.

On July 7, 2026, the company disclosed a $28 million Series B round led by Valspring Capital, with existing investor M33 Growth also participating. Pediatrica said it had grown to 21 locations across Florida and Texas and intended to use the additional capital for both organic expansion and further strategic acquisitions.

That financing is the strongest reason Palenzuela matters as a healthcare business figure now rather than merely as a former executive from earlier managed-care companies.

The Business Pattern Behind His Career

Taken together, Palenzuela’s career reveals a fairly consistent model.

First came regulatory and corporate-law experience. Then came direct responsibility inside healthcare organizations. After that came executive operations, physician network management, outside growth capital, and acquisitions.

ClareMedica and Pediatrica serve different populations—one centered heavily on senior primary care and Medicare Advantage, the other on children—but their underlying strategy is similar: provide independent or acquired medical practices with centralized infrastructure, reduce administrative burdens, build payer and provider relationships, invest in technology, and expand the network.

That is a more useful way of understanding Palenzuela than simply calling him an entrepreneur.

He has spent decades building the organizational machinery around doctors.

Public Service Beyond His Companies

Palenzuela has also maintained a documented connection to nonprofit and educational organizations.

The National Parkinson Foundation elected him to its board in 2014. Later Parkinson’s Foundation records continued to identify him as a director, and in 2022 the organization announced his transition to its Emeritus Board.

University of Miami records have also listed him among alum leadership and the university’s Citizens Board, reinforcing a continuing institutional relationship with his alma mater.

What Remains Private

Palenzuela has a substantial corporate paper trail but a comparatively limited personal one.

Authoritative sources reviewed for this profile do not establish a verified public date of birth, a detailed account of his childhood, parents, home life, or a comprehensive family history. Those gaps should not be filled with assumptions drawn from people-search databases or biography aggregators.

The same caution applies to his finances.

Verified personal net-worth data has not been publicly disclosed. Although Palenzuela has held executive positions in companies involved in transactions worth hundreds of millions of dollars and has participated in privately financed businesses, corporate transaction values cannot legitimately be converted into an individual’s personal fortune. His current ownership percentage in Pediatrica and the financial terms of several private transactions also have not been fully disclosed publicly.

Roberto Palenzuela’s Place in Healthcare

Palenzuela’s biography is ultimately less about public visibility than institutional scale.

The documented record runs from healthcare law in the 1990s through Continucare and Metropolitan Health Networks to operational leadership at ClareMedica, and now Pediatrica. Along the way, he has worked through publicly traded healthcare companies, private-equity-backed organizations, and physician networks serving markedly different patient populations.

Pediatrica is now the most important test of that accumulated experience. With $28 million in new financing and a network reported at 21 locations as of July 2026, Palenzuela is trying to show that the infrastructure-and-acquisition model he used in adult value-based care can also scale pediatric primary care without losing the local relationships pediatric practices depend on.

Whether that model ultimately produces durable clinical and financial outcomes will take time and evidence. For now, the verified story is substantial enough without embellishment: Roberto L. Palenzuela is a lawyer-turned-healthcare operator whose career has increasingly focused on building and scaling physician care organizations rather than simply advising them.

businessbiohub.com